Biodexa Pharmaceuticals PLC
NASDAQ:BDRX
Biodexa Pharmaceuticals PLC
NASDAQ:BDRX
Price:
1.24
USD
-4.62%
Market Closed
Market Cap:
$768.2k
Cash Flow Statement
Cash Flow Statement
Biodexa Pharmaceuticals PLC
Biodexa Pharmaceuticals PLC
Currency: GBP
| Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||
| Net Income |
(5)
|
(8)
|
(8)
|
(7)
|
(7)
|
(6)
|
(6)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(3)
|
(2)
|
|
| Cash Taxes Paid |
0
|
(1)
|
0
|
(1)
|
0
|
(0)
|
(0)
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
1
|
1
|
1
|
1
|
(0)
|
(4)
|
(2)
|
|
| Cash from Operating Activities |
(6)
N/A
|
(7)
-9%
|
(7)
-5%
|
(7)
+8%
|
(8)
-14%
|
(12)
-58%
|
(11)
+12%
|
|
| Investing Cash Flow | ||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
|
| Other Items |
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
-49%
|
(0)
+17%
|
(0)
-45%
|
(1)
-292%
|
(1)
+42%
|
(0)
+69%
|
|
| Financing Cash Flow | ||||||||
| Net Issuance of Common Stock |
9
|
0
|
7
|
10
|
9
|
8
|
10
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Other |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
|
| Cash from Financing Activities |
9
N/A
|
0
-99%
|
6
+13 468%
|
10
+60%
|
9
-16%
|
9
-1%
|
10
+16%
|
|
| Change in Cash | ||||||||
| Effect of Foreign Exchange Rates |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
2
N/A
|
(7)
N/A
|
(1)
+83%
|
3
N/A
|
(0)
N/A
|
(4)
-2 401%
|
(1)
+76%
|
|
| Free Cash Flow | ||||||||
| Free Cash Flow |
(7)
N/A
|
(7)
-8%
|
(7)
-4%
|
(7)
+4%
|
(9)
-25%
|
(13)
-47%
|
(11)
+15%
|
|
Switch to:
Switch to:
See Also
Discover More
